ライフサイエンスコーパス: carcinoid syndrome

1 urvival compared with those patients without carcinoid syndrome.

2 diagnosed with NETs, of whom 1786 (19%) had carcinoid syndrome.

3 cause distinct clinical syndromes, including carcinoid syndrome.

4 , becoming much more common in patients with carcinoid syndrome.

5 nd pulmonary insufficiency) in patients with carcinoid syndrome.

6 All patients with MCH had carcinoid syndrome.

7 Cardiac metastases are uncommon in carcinoid syndrome.

8 egral part of the echo exam in patients with carcinoid syndrome.

9 more often with flushing, diarrhea, and the carcinoid syndrome.

10 ical presentation, except in the case of the carcinoid syndrome.

11 ted levels of 5-HIAA without any evidence of carcinoid syndrome.

12 number of metastatic sites, and presence of carcinoid syndrome.

13 wel movement (BM) frequency in patients with carcinoid syndrome.

14 ars [95% CI 4.5-5.4]) than did those without carcinoid syndrome (5.6 years [5.4-5.9]; hazard ratio 1.

15 se is a frequent occurrence in patients with carcinoid syndrome and is responsible for substantial mo

16 oid poisoning, vasoactive amine intolerance, carcinoid syndrome and phaeochromocytoma.

17 l serotonin is associated with symptoms like carcinoid syndrome and pulmonary arterial hypertension.

18 egression to assess the relationship between carcinoid syndrome and survival.

19 rkinson's disease, pain treatment, malignant carcinoid syndrome, and prostate cancer.

20 [5-hydroxytryptamine (5-HT)] levels, such as carcinoid syndrome, and the use of serotonin agonists, s

21 cells causes severe symptoms typical for the carcinoid syndrome, and tryptophan hydroxylase inhibitor

22 More patients with carcinoid tumors and carcinoid syndrome are requiring anesthesia and surgery.

23 ignificantly associated with the presence of carcinoid syndrome at diagnosis (p=0.07).

24 ved, octreotide LAR controls the symptoms of carcinoid syndrome at least as well as SC octreotide.

25 es the diarrhea and flushing associated with carcinoid syndrome but requires long-term multiple injec

26 noid valvular heart disease in patients with carcinoid syndrome by serial echocardiography, correlati

27 The proportion of patients with carcinoid syndrome compared with those without did not d

28 Carcinoid syndrome complicated only 1 of the cases.

29 nd enable future research into the effect of carcinoid syndrome control on patient survival.

30 7 patients with documented liver metastases, carcinoid syndrome developed in only 13 patients (48%),

31 insurance claims of flushing, diarrhoea, or carcinoid syndrome during the 3 months before and after

32 However, carcinoid syndrome frequency in the NET population has n

33 Patients with carcinoid syndrome had a shorter overall survival (media

34 All 13 patients with carcinoid syndrome had elevated levels of 5-HIAA, but th

35 Symptoms and survival of patients with carcinoid syndrome have improved, but development of car

36 , primarily of the appendix, associated with carcinoid syndrome in 10% of patients.

37 sed the proportion of patients with NETs and carcinoid syndrome in the USA and associated clinical fa

38 an-Armitage trend test to identify trends in carcinoid syndrome incidence and Cox regression to asses

39 The number of patients with NETs and carcinoid syndrome increased from 50 (11%) of 465 patien

40 rong recommendation was made for symptomatic carcinoid syndrome informing treatment in midgut neuroen

41 This population-based analysis reveals that carcinoid syndrome is significantly associated with tumo

42 Conclusion Among patients with carcinoid syndrome not adequately controlled by somatost

43 tients with MEN, particularly those with the carcinoid syndrome or pheochromocytoma, to undergo surge

44 cant difference in the reported incidence of carcinoid syndrome (p<0.0001), as was tumour grade, stag

45 was used more frequently in patients without carcinoid syndrome (p=0.009); use of radiotherapy was no

46 ch develops in the majority of patients with carcinoid syndrome, presents the anesthesiologist with m

47 ctive study, we identified 200 patients with carcinoid syndrome referred for echocardiography in whom

48 (p=0.003) were more common in patients with carcinoid syndrome than in those without it, whereas sur

49 Twenty-three patients with carcinoid syndrome underwent serial echocardiographic ex

50 mes such as xanthomas, acanthosis nigricans, carcinoid syndrome, unusual erythematous eruptions such

51 cteristics between patients with and without carcinoid syndrome using chi(2) tests.

52 Patients with carcinoid syndrome were more frequently female than male

53 Our sample included 71 patients with the carcinoid syndrome who underwent serial echocardiographi

54 ale, carcinoid tumor of the lung, and active carcinoid syndrome with high levels of serotonin.

55 oactive amines into the bloodstream, causing carcinoid syndrome, with symptoms including flushing and